K+ sparing diuretic
Jump to navigation
Jump to search
Indications
- treatment of hypertension
- weak blood pressure lowering effects in most patients
- adjunctive treatment of heart failure
Monitor
Drug interactions
- hyperkalemia potentiated by concomitant use of
- drug interaction(s) SGLT2 inhibitors (flozins) with diuretics
- drug interaction(s) of diuretics in combination with Zn+2
- drug interaction(s) of antiarrhythmic agents in combination with diuretics
- drug interaction(s) of calcium channel blockers with diuretics
- drug interaction(s) of spironolactone with potassium-sparing diuretics
- drug interaction(s) of ACE inhibitors with potassium-sparing diuretics
- drug interaction(s) of diuretics with angiotensin II receptor antagonists
- drug interaction(s) of diuretics with ACE inhibitors
- drug interaction(s) of NSAIDs, diuretics & angiotensin II receptor antagonists
- drug interaction(s) of NSAIDs, diuretics & ACE inhibitors
- drug interaction(s) of NSAIDs & antihypertensives
Mechanism of action
- site of action: distal tubule & collecting duct
More general terms
More specific terms
- amiloride (Midamor, Amipramidin, Modamide)
- epleronone (Inspra)
- spironolactone (Aldactone)
- triamterene (Dyrenium)
References
- ↑ Prescriber's Letter 16(2): 2008 Comparison of Commonly Used Diuretics Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=250214&pb=PRL (subscription needed) http://www.prescribersletter.com